8. clinical presentation
TRANSCRIPT
-
7/29/2019 8. Clinical Presentation
1/20
CLINICALCLINICAL
-
7/29/2019 8. Clinical Presentation
2/20
Wide range of symptoms and signs isWide range of symptoms and signs is
related to:related to:
1. Histologic features which often help determinethe anatomic site of origin in the lung
2. The specific tumor location in the lung and itsrelationship to surrounding structures
3. Biologic features and the production of avariety of paraneoplastic syndromes
4. The presence or absence of metastatic disease
-
7/29/2019 8. Clinical Presentation
3/20
Clinical Presentation of Lung CancerClinical Presentation of Lung Cancer
Pulmonary symptoms
Cough Bronchus irritation orcompression
Dyspnea Airway obstruction orcompression
Wheezing >50% airway obstruction
-
7/29/2019 8. Clinical Presentation
4/20
Nonpulmonary thoracic symptomsHemoptysis Tumor erosion or irritation
Pneumonia Airway obstruction
Pleuritic pain Parietal pleural irritation or invasion
Local chest Rib and/or muscle involvement
wall pain
-
7/29/2019 8. Clinical Presentation
5/20
Radicular chest pain Intercostal nerve involvement
Pancoast's syndrome Stellate ganglion, chest wall,brachial
plexus involvement
Hoarseness Recurrent laryngeal nerveinvolvement
Swelling of head and arms :1.Bulky involved mediastinal
lymph nodes
2.Medially based right upper lobe
-
7/29/2019 8. Clinical Presentation
6/20
TUMOR HISTOLOGYTUMOR HISTOLOGY
Squamous cell and small cell carcinomas:Arise in main lobar, or first
segmental bronchi{centralairways}
Adenocarcinomas: located peripherally,Asymptomatic peripheral lesion on chest
radiograph
BAC : solitary nodule, as multifocal nodules, or as a
diffuse infiltrate mimicking(PNEUMONIC FORM)air bronchograms may be seen radiographically
within the tumor
-
7/29/2019 8. Clinical Presentation
7/20
SITE OF TUMORS
Squamous cell = 66% occur centrally in lunghilus(sq=central)
Adenocarcinoma = Peripheral,
Small (oat) cell = Central, highly malignant,usually not operable
Large cell = Usually peripheral, verymalignant
-
7/29/2019 8. Clinical Presentation
8/20
-
7/29/2019 8. Clinical Presentation
9/20
Nonpulmonary Thoracic Symptoms
OCCURS DUE TO invasion of the primary tumor directlyinto a contiguous structure or from mechanicalcompression of a structure by enlarged tumor-bearinglymph nodes
Peripherally located tumors ( adenocarcinomas)extending through the visceral pleura lead to irritationor growth into the parietal pleura and to continuedgrowth into the chest wall structures
SYMPTOMS depending on the extent of chest wall
involvement1.pleuritic pain
2.localized chest wall pain
3.radicular pain
-
7/29/2019 8. Clinical Presentation
10/20
Superior sulcus tumors (usuallyadenocarcinomas)
may produce the Pancoast syndromeTumoratthe apex of the lung or superior sulcus that mayinvolve the brachial plexus, sympathetic ganglia,
and vertebral bodies, leading to pain, upperextremity weakness, and
Horners syndrome
Injury to the cervical sympathetic chain(MAP)
1. Miosis (small pupil)
2. Anhydrosis of ipsilateral face
3. Ptosis
Depending on the exact tumor location, symptoms
can include
-
7/29/2019 8. Clinical Presentation
11/20
Invasion of the primary tumor into the mediastinummay lead to involvement of the phrenic or recurrent laryngealnerves. Direct invasion of the phrenic nerve occurs withtumors of the medial surface of the lung, or with anterior hilartumors.
Symptoms may include
1.shoulder pain (referred),
2.hiccups, and dyspnea with exertion
Because of diaphragm paralysis
Diagnosis;chest radiograph,fluoroscopic examination of thediaphragm and with breathing and sniffing (the sniff test)
-
7/29/2019 8. Clinical Presentation
12/20
Recurrent laryngeal nerve (RLN)
most commonly occurs on the left side.
Paralysis may occur
1. invasion of the vagus nerve above the aortic arch by amedially based left upper lobe (LUL) tumor,
2.invasion of the RLN directly by a hilar tumor,
3.invasion by hilar or aortopulmonary lymph nodes
involved with metastatic tumor.
-
7/29/2019 8. Clinical Presentation
13/20
Symptoms:
Voice change,often referred to as hoarseness,
Loss of tone associated with a breathy quality,
Coughing( when drinking liquids)
-
7/29/2019 8. Clinical Presentation
14/20
Tumor BiologyTumor Biology
Lung cancers both nonsmall-cell andsmall-cellcarcinoma
Capable of producing a variety of paraneoplasticsyndrome
Most often from tumor production and release ofbiologically active materials systemically.
Majority ofsuch syndromes are caused by small-cellcarcinomas, including many endocrinopathies.
-
7/29/2019 8. Clinical Presentation
15/20
Paraneoplastic syndromes
Early diagnosis. Presence does not influence resectabilityor the potential to successfully treat the tumor.
Symptoms of the syndrome often will abate with
successful treatment, and recurrence may be heraldedby recurrent paraneoplastic symptoms.
5 general types of paraneoplastic syndromes.
1. Metabolic: Cushings, SIADH, hypercalcemia
2. Neuromuscular: Eaton-Lambert,cerebellar ataxia3. Skeletal: hypertrophic osteoarthropathy
4. Dermatologic: acanthosis nigricans
5. Vascular: thrombophlebitis
-
7/29/2019 8. Clinical Presentation
16/20
SCLC :: hypertrophic pulmonaryosteoarthropathy (HPO)
Most common paraneoplasticsyndromes
Syndrome is characterized by tenderness andswelling of the ankles, feet, forearms, and hands.
Because of periostitis of the fibula, tibia, radius,metacarpals, and metatarsals.
-
7/29/2019 8. Clinical Presentation
17/20
HypercalcemiaHypercalcemia
10% of patients with lung cancer and is most oftenbecause of metastatic disease
15 % of cases are because of secretion of ectopicparathyroid hormonerelated peptide, most often
with squamous cell carcinoma
Diagnosis of ectopic parathyroid hormone secretioncan be made by measuring elevated serum levels
of parathyroid hormone; the clinician must also ruleout concurrent metastatic bone disease by a bonescan.
-
7/29/2019 8. Clinical Presentation
18/20
Metastatic SymptomsMetastatic Symptoms
METASTASES occur most commonly
Central nervous system (CNS),
Vertebral bodies,
Bones,Liver,
Adrenal glands,
Lungs,Skin and Soft tissues.
10 % of patients with lung cancer have CNSmetastases
1015 %will develop CNS metastases
SYMPTOMS: headache, nausea and vomiting,
seizures, hemiplegia, and speech difficulty.
-
7/29/2019 8. Clinical Presentation
19/20
Nonspecific SymptomsNonspecific Symptoms
Lung cancer often produces a variety ofnonspecific symptoms such as
Anorexia
Weight loss
Fatigue
Malaise
The cause of these symptoms is oftenunclear, should raiseconcern about possible metastatic disease
-
7/29/2019 8. Clinical Presentation
20/20
END............................................................